E Fund(Hk)Solactive Biopharma Select Index Etf(03186.HK) Rises 1.69% in Morning Session, Average Traded Price at HK$13.228
NewTimeSpace News: As at 10:21 on June 23, 2026, E Fund(Hk)Solactive Biopharma Select Index Etf(03186.HK) gained 1.69% to HK$13.260. The ETF traded 19,900 units with a total turnover of HK$263,200 and an average traded price of HK$13.228. Its current net asset value per unit is HK$13.179, total assets under management stand at HK$26.358 million, and one trading lot contains 100 units.
E Fund(Hk)Solactive Biopharma Select Index Etf(03186.HK) tracks the Solactive Select Biotech Index (Net Total Return). The index selects 100 constituent stocks from biopharmaceutical companies listed in Hong Kong and the United States, covering multiple global innovation hubs including China, the United States, Europe, Israel, Switzerland and Japan.
NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.
- E Fund(Hk)Solactive Biopharma Select Index Etf(03186.HK) Drops 0.53% Intraday, Average Price at HK$13.227
- E Fund(Hk)Solactive Biopharma Select Index Etf(03186.HK) Rises 1.09% Intraday at an Average Price of HK$12.938
- CSOP Hang Seng HK-US TECH ETF (03442.HK) Falls 3.83% in Afternoon Trade, Latest NAV at HKD 7.511
- Ishares Core Msci Taiwan Index Etf (03074.HK) Falls 4.10% in Afternoon Trade, Turnover at HKD 7.3026 Million
- PICO FAR EAST(00752.HK): FY 25/26 Interim Report - Profit Attributable to Shareholders stood at HKD 207.92 million, YoY decrease of 2.08%